Skip to content
2000
Volume 24, Issue 6
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

There is no abstract available.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152062404240207175250
2024-04-01
2025-05-29
Loading full text...

Full text loading...

/deliver/fulltext/acamc/24/6/ACAMC-24-6-01.html?itemId=/content/journals/acamc/10.2174/187152062404240207175250&mimeType=html&fmt=ahah

References

  1. Bei, R.; Kantor, J.; Kashmiri, S.V.S.; Abrams, S.; Schlom, J. Enhanced immune responses and anti-tumor activity by baculovirus recombinant Carcinoembryonic antigen (CEA) in mice primed with the recombinant vaccinia CEA.J. Immunother.199416275282
    [Google Scholar]
  2. Masuelli, L.; Fantini, M.; Benvenuto, M.; Sacchetti, P.; Giganti, M.G.; Tresoldi, I.; Lido, P.; Lista, F.; Cavallo, F.; Nanni, P.; Schlom, J.; Modesti, A.; Bei, R. Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells.J. Transl. Med.201412122
    [Google Scholar]
  3. Focaccetti, C.; Benvenuto, M.; Ciuffa S.; Fazi, S.; Scimeca, M.; Nardi, A.; Miele, M.T.; Battisti, A.; Bonanno, E.; Modesti, A.; Masuelli, L.; Bei, R. Curcumin enhances the antitumoral effect induced by the recombinant vaccinia neu vaccine (rV-neuT) in mice with transplanted salivary gland carcinoma cells.Nutrients2020,14, 12:1417.
    [Google Scholar]
  4. Bei, R.; Masuelli, L.; Moriconi, E.; Visco, V.; Moretti, A.; Kraus, M.H.; Muraro, R. Immune responses to all ErbB family receptors detectable in serum of cancer patients.Oncogene19991812671275
    [Google Scholar]
  5. Bei, R.; Budillon, A.; Reale, M.G.; Capuano, G.; Pomponi, D.; Budillon, G.; Frati, L.; Muraro, R. Cryptic epitopes on alpha-fetoprotein (AFP) induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis and chronic hepatitis patients.Cancer Res.19995954715474
    [Google Scholar]
  6. Benvenuto, M.; Sileri, P.; Rossi, P.; Masuelli, L.; Fantini, M.; Nanni, M.; Franceschilli, L.; Sconocchia, G.; Lanzilli, G.; Arriga, R.; Faggioni, G.; Lista, F.; Orlandi, A.; Manzari, V.; Gaspari, A.; Modesti, A.; Bei, R. Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients.J. Transl. Med.201513101
    [Google Scholar]
  7. Farina, A.; Santarelli, R.; Gonnella, R.; Bei, R.; Muraro, R.; Cardinali, G.; Uccini, S.; Ragona, G.; Frati, L.; Faggioni, A.; Angeloni, A. The BFRF1 gene of the Epstein-Barr virus encodes a novel protein.J. Virol.20007432353244
    [Google Scholar]
  8. Santarelli, R.; Farina, A.; Granato, M.; Gonnella, R.; Raffa, S.; Leone, L.; Bei, R.; Modesti, A.; Frati, L.; Torrisi, M.R.; Faggioni A. Identification and characterization of the product encoded by ORF69 of Kaposi’s sarcoma-associated herpesvirus.J. Virol.20088245624572
    [Google Scholar]
  9. Masuelli, L.; Marzocchella, L.; Focaccetti, C.; Tresoldi, I.; Palumbo, C.; Izzi, V.; Benvenuto, M.; Fantini, M.; Lista, F.; Tarantino, U.; Modesti, A.; Galvano, F.; Bei, R. Resveratrol and Diallyl disulfide potentiate curcumin-induced apoptosis in rabdomyosarcoma and osteosarcoma cell lines.Front. Biosci. (Landmark Ed)201217498508
    [Google Scholar]
  10. Benvenuto M.; Mattera R.; Sticca J.I.; Rossi P.; Cipriani C.; Giganti M.G.; Volpi A.; Modesti A.; Masuelli L.; Bei R. Effect of the BH3 Mimetic Polyphenol (-)-Gossypol (AT-101) on the in vitro and in vivo Growth of Malignant Mesothelioma.Front. Pharmacol.201891269
    [Google Scholar]
  11. Benvenuto, M.; Ciuffa, S.; Focaccetti, C.; Sbardella, D.; Fazi, S.; Scimeca, M.; Tundo, G.R.; Barillari, G.; Segni, M.; Bonanno, E.; Manzari, V.; Modesti, A.; Masuelli, L.; Coletta, M.; Bei, R. Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells.Sci. Rep.20211119051
    [Google Scholar]
  12. Bei R.; Benvenuto M.; Focaccetti C.; Fazi S.; Moretti M.; Nardozi D.; Angiolini V.; Ciuffa S.; Cifaldi L.; Carrano R.; Palumbo C.; Miele M.T.; Bei R.; Barillari G.; Manzari V.; De Smaele E.; Modesti A.; Masuelli L. Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo.J. Transl. Med.202220286
    [Google Scholar]
  13. Benvenuto, M.; Angiolini, V.; Focaccetti, C.; Nardozi, D.; Palumbo, C.; Carrano, R.; Rufini, A.; Bei, R.; Miele, M.T.; Mancini, P.; Barillari, G.; Cirone, M.; Ferretti, E.; Tundo, G.R.; Mutti, L.; Masuelli, L.; Bei, R. Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo.Biol. Direct20231817
    [Google Scholar]
/content/journals/acamc/10.2174/187152062404240207175250
Loading

  • Article Type:
    In Brief
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test